Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Drug Office Reform: 'Everything' Is On The Table

Nov 15 2017

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

Jul 18 2016

Don't Rush To Reorganize FDA, McClellan Says

Feb 29 2016

CDER Director Woodcock Plans Changes To Drug Reviews During OND Transition

Mar 07 2017

Gottlieb's FDA: Specialized Groups Could Create Review Consistency, Speed

Mar 24 2017

Gottlieb Promotes 'Team' Work For Product Reviews

Nov 03 2017

FDA's Pazdur Jumps Over To New 'Moonshot' Role

Jun 30 2016

Additional Topics

United States Drug Review Review Pathway FDA Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.